Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 25, 2026Discover OncologyOpen Access

Targeting the m6A reader YTHDF1 for overcoming cancer therapeutic resistance and enhancing tumor immunotherapy

View Full Paper
Ask AI
Bookmark
Share

Authors

HWHaipeng WangYZYi ZhangLLLingyun Li

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Wang et al. (2026) studied this question.

synapsesocial.com/papers/6ab60fdf406bf401c1468d78https://doi.org/10.1007/s12672-026-05962-6
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Decoding m6A readers: roles of YTHDF proteins in leukemogenesis and cancer immunity2025
  2. 2Emerging role of RNA modification reader YTHDF2 in hematopoiesis, immunity, and cancer2026
  3. 3YTHDF2 upregulation and relocation dictate CD8 T cell polyfunctionality in tumor immunity2024
  4. 4YTHDF2 favors protumoral macrophage polarization and implies poor survival outcomes in triple negative breast cancer2024 · 14 citations
  5. 5Data from <i>N<sup>6</sup></i>-Methyladenosine Reader YTHDF1 Promotes Stemness and Therapeutic Resistance in Hepatocellular Carcinoma by Enhancing NOTCH1 Expression2024